Lab21 signs a license with Celera for one of the first diagnostic tests for cirrhosis risk in hepatitis C patients
Lab21 announced that it has obtained a licence from Celera, an Applera Corporation business, to provide access to its test for cirrhosis risk in patients with chronic hepatitis C viral (HCV) infection in the UK and Ireland.
The test, known as CRS7, is the first clinical test capable of predicting the likelihood of an HCV patient's risk of progressing to liver fibrosis and cirrhosis. According to the company, the availability of this test will substantially aid in the clinical management of HCV patients by ensuring they receive accurate, personalised treatment. The test has been clinically validated through multi-centre studies in North America.
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Breakthrough technology to rapidly identify unknown molecules at scale - Start-up Isospec Analytics raises $1.9m
Indicator of early form of Parkinson’s in stool sample
Agilent Technologies Publishes Industry’s First Compendium to Test for Synthetic Marijuana Compounds
Neuronal Parkinson inclusions are different than expected - Study raises new questions about the etiology of Parkinson’s disease
World's first toxicology testing strategy without animal testing adopted by OECD - Success for long-standing collaboration between BASF and Givaudan to develop and validate alternative methods
X-TubeProcessor_Smart | Laboratory robots | HTI Automation
Watching Molecular Machines at Work